GlassScriptPhysician profile
Cassandra Lundberg
NPI 1285287755
$2,459.79
in general payments reported to CMS, 2019-2025
30 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $508 · 2022: $512 · 2023: $705 · 2024: $279 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $389.88 | 2021-2025 | |
| Pfizer INC. | $283.10 | 2021-2023 | |
| Medtronic, INC. | $197.50 | 2023-2025 | Corevalve Evolut R, Micra, Onyx Frontier |
| Astellas Pharma US INC | $193.11 | 2021-2022 | |
| Amgen INC. | $183.85 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $154.70 | 2023-2025 | Watchman Flx, Watchman Access System |
| Merck Sharp & Dohme LLC | $122.18 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $114.01 | 2022-2024 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $108.91 | 2022-2023 | Optimizer |
| Itamar Medical INC | $87.00 | 2023 | Watchpatone |
| Kiniksa Pharmaceuticals, LTD. | $70.13 | 2022-2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $61.12 | 2021-2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $60.38 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $55.38 | 2021-2025 | Wainua, Farxiga |
| Abbott Laboratories | $45.23 | 2024-2025 | Amplatzer Amulet, Cardiomems |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $42.50 | 2021-2023 | Nexletol |
| Amarin Pharma, INC. | $33.82 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $32.71 | 2022 | |
| Baxter Healthcare | $31.79 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lundbeck LLC | $24.83 | 2021 | |
| Genzyme Corporation | $22.69 | 2025 | |
| Edwards Lifesciences Corporation | $21.35 | 2023 | Pascal |
| Lexicon Pharmaceuticals, INC. | $21.06 | 2023 | Inpefa |
| Alnylam Pharmaceuticals INC. | $19.07 | 2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $19.01 | 2025 | |
| Amryt Pharma Holdings LTD | $18.14 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.81 | 2023 | |
| Heartflow, INC. | $13.99 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $11.65 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.89 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Lundberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.